Bio-Rad Laboratories Class A
507 hedge funds and large institutions have $14.4B invested in Bio-Rad Laboratories Class A in 2021 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 171 increasing their positions, 198 reducing their positions, and 44 closing their positions.
40% more call options, than puts
Call options by funds: $76.4M | Put options by funds: $54.5M
16% more capital invested
Capital invested by funds: $12.4B → $14.4B (+$2.01B)
11% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 44
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0.12% less ownership
Funds ownership: 78.65% → 78.53% (-0.12%)
0% less funds holding
Funds holding: 508 → 507 (-1)
14% less repeat investments, than reductions
Existing positions increased: 171 | Existing positions reduced: 198
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$244M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$51.6M |
| 3 |
SEI Investments
Oaks,
Pennsylvania
|
+$50.3M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$48.5M |
| 5 |
Millennium Management
New York
|
+$32.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$75.2M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$71.7M |
| 3 |
BlackRock
New York
|
-$63.8M |
| 4 |
HP
Hound Partners
New York
|
-$46.6M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$42.4M |
BIO Hedge Fund Activity: Q3 2021 in Review
507 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2021, worth a combined $14.4B — up 16% from $12.4B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new BIO positions and 44 closed out — a net gain of 5 holders — while 171 added to existing stakes and 198 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $244M. The largest seller was Deutsche Bank, cutting an estimated $75.2M.
- 507 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2021, down from 508 in Q2 2021.
- Funds reported $14.4B of Bio-Rad Laboratories Class A stock for Q3 2021, up 16% quarter-over-quarter.
- 49 funds opened new Bio-Rad Laboratories Class A positions in Q3 2021 and 44 closed out, a net change of +5 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q3 2021 was Fidelity Investments, an estimated $244M added.
- The largest Bio-Rad Laboratories Class A seller in Q3 2021 was Deutsche Bank, an estimated $75.2M sold.
Based on aggregated 13F filings for Q3 2021.